Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study.
Saved in:
| Title: | Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study. |
|---|---|
| Authors: | Nahi, Hareth1 (AUTHOR), Usmani, Saad Z.2 (AUTHOR), Mateos, Maria-Victoria3 (AUTHOR), van de Donk, Niels W. C. J.4 (AUTHOR), Oriol, Albert5 (AUTHOR), Plesner, Torben6 (AUTHOR), Bandyopadhyay, Nibedita7 (AUTHOR), Hellemans, Peter8 (AUTHOR), Tromp, Brenda9 (AUTHOR), Nnane, Ivo7 (AUTHOR), Zemlickis, Donna10 (AUTHOR), Chari, Ajai11 (AUTHOR), Moreau, Philippe12 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Feb2023, Vol. 64 Issue 2, p468-472. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
